UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03933 UNITED LAB

Not Yet Opened 04-16 16:08:12

10.230

-0.080

-0.78%

High10.310	Low10.100	Vol5.24M
Open10.300	D1 Closing10.310	Amplitude2.04%
Mkt Cap20.18B	Tradable Cap20.18B	Total Shares1.97B
T/O53.41M	T/O Rate0.27%	Tradable Shares1.97B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03933","market":"HK","secType":"STK","nameCN":"UNITED LAB","latestPrice":10.23,"timestamp":1776326892008,"preClose":10.31,"halted":0,"volume":5238000,"delay":0,"changeRate":-0.007759456838021345,"floatShares":1973000000,"shares":1973000000,"eps":1.2691564177399415,"marketStatus":"Not Yet Opened","change":-0.08,"latestTime":"04-16 16:08:12","open":10.3,"high":10.31,"low":10.1,"amount":53405588,"amplitude":0.020369,"askPrice":10.23,"askSize":14000,"bidPrice":10.2,"bidSize":28000,"shortable":3,"etf":0,"ttmEps":1.341990970407349,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"listingDate":1181836800000,"exchange":"SEHK","adjPreClose":10.31,"dividendRate":0.046432,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.6658018953228588,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03933","defaultTab":"news","newsList":[{"id":"1167035585","title":"GTHT Securities Maintains \"Add\" Rating on UNITED LAB with HK$15.53 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1167035585","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167035585?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:20","pubTimestamp":1776068442,"startTime":"0","endTime":"0","summary":"GTHT Securities has released a research report indicating that as the active pharmaceutical ingredient (API) business gradually emerges from the bottom of its cycle, core business profits are...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02611","BK1564","03933","BK1191","EWH","161027","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625947028","title":"Assessing United Laboratories International Holdings (SEHK:3933) Valuation After Positive UBT251 Phase 2 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2625947028","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625947028?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:28","pubTimestamp":1775644137,"startTime":"0","endTime":"0","summary":"Phase 2 data on UBT251 puts United Laboratories International Holdings in focus\nUnited Laboratories International Holdings (SEHK:3933) drew investor attention after releasing phase 2 data for UBT251 in China, showing HbA1c and body weight reductions against placebo and semaglutide in type 2 diabetes patients.\nThe topline readout matters because it moves UBT251 closer to late stage development, supports the start of phase 3 trials in China, and ties directly into the company’s broader diabetes...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/assessing-united-laboratories-international-holdings-sehk393-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK4211","03933","UBCP","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166178711","title":"United Laboratories Keeps Issued Share Capital Steady at 1.97 Billion in March 2026 Monthly Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1166178711","media":"Bulletin Express","labels":["shareholding","SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166178711?lang=en_us&edition=fundamental","pubTime":"2026-04-02 22:43","pubTimestamp":1775141036,"startTime":"0","endTime":"0","summary":"The United Laboratories International Holdings Limited filed its monthly return for the period ended 31 March 2026, confirming that both authorised and issued share capital remained unchanged during...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129334695","title":"United Laboratories Issues Clarification on Final Dividend Record Date, Deletes “Special Dividend” Reference","url":"https://stock-news.laohu8.com/highlight/detail?id=1129334695","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129334695?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:23","pubTimestamp":1774931029,"startTime":"0","endTime":"0","summary":"Hong Kong, 31 March 2026—The United Laboratories International Holdings Limited (United Laboratories) has released a clarification to its 2025 annual results announcement dated 24 March 2026,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623372573","title":"United Labs deletes “special dividend” wording from annual results dividend timetable","url":"https://stock-news.laohu8.com/highlight/detail?id=2623372573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623372573?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:14","pubTimestamp":1774930471,"startTime":"0","endTime":"0","summary":"United Laboratories issued a clarification to its FY2025 annual results announcement, correcting an inadvertent reference to a “special dividend” in register-closure wording.Revised disclosure covers entitlement to final dividend, with share register closed July 9-10, 2026.All other information in results announcement remains unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbrmWf3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154561003","title":"CICC Maintains Outperform Rating on UNITED LAB with Target Price of HK$16.00","url":"https://stock-news.laohu8.com/highlight/detail?id=1154561003","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154561003?lang=en_us&edition=fundamental","pubTime":"2026-03-27 10:30","pubTimestamp":1774578638,"startTime":"0","endTime":"0","summary":"CICC has issued a research report stating that due to pricing pressures on active pharmaceutical ingredients (APIs) and intermediates, it has lowered its net profit forecasts for UNITED LAB (03933)...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184394616","title":"United Laboratories Declares RMB0.26 Final Dividend for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1184394616","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184394616?lang=en_us&edition=fundamental","pubTime":"2026-03-26 16:44","pubTimestamp":1774514651,"startTime":"0","endTime":"0","summary":"United Laboratories International Holdings Limited has announced a final ordinary cash dividend of RMB0.26 per share for the financial year ended 31 December 2025. Key timetable   • Ex-dividend date:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622371728","title":"United Laboratories FY2025 proposes final dividend; RMB 0.26 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622371728","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622371728?lang=en_us&edition=fundamental","pubTime":"2026-03-26 16:32","pubTimestamp":1774513960,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL2qt79S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151521866","title":"Stock Track | UNITED LAB Plummets 5.06% Intraday After UBS Cuts Target Price on Weak Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=1151521866","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151521866?lang=en_us&edition=fundamental","pubTime":"2026-03-26 15:47","pubTimestamp":1774511226,"startTime":"0","endTime":"0","summary":"UNITED LAB's stock price plummeted 5.06% during intraday trading on Thursday, following the release of a research report from UBS.The decline comes after UBS adjusted its forecasts for the company,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123081897","title":"UBS Trims UNITED LAB Target Price to HK$17.6, Citing In-Line Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1123081897","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123081897?lang=en_us&edition=fundamental","pubTime":"2026-03-26 14:16","pubTimestamp":1774505817,"startTime":"0","endTime":"0","summary":"UBS has released a research report adjusting its forecasts for UNITED LAB (03933), noting a slight reduction in early milestone payments for UBT251. The firm has lowered its earnings per share...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622003191","title":"United Laboratories International Holdings (SEHK:3933) Margin Compression Challenges Bullish Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2622003191","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622003191?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:08","pubTimestamp":1774444119,"startTime":"0","endTime":"0","summary":"How United Laboratories International Holdings' Latest Numbers Set the Stage for the Narrative\nUnited Laboratories International Holdings (SEHK:3933) has put up a busy FY 2025 first half, with revenue of about C¥7.5b and basic EPS of C¥1.04 sitting against trailing twelve month revenue of roughly C¥14.1b and basic EPS of C¥1.69. Investors are sifting through what the shift in earnings power really means. Over the last three reported half year periods, revenue has moved from C¥7.2b in 1H 2024...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/united-laboratories-international-holdings-sehk3933-margin-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3933/united-laboratories-international-holdings-shares/news/united-laboratories-international-holdings-sehk3933-margin-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BLSX","03933","BK4211","BLSG","BK1191","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622757020","title":"BRIEF-United Laboratories International Says Progress In Clinical Trial Of UBT251 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2622757020","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622757020?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:27","pubTimestamp":1774438077,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Says Progress In Clinical Trial Of UBT251 InjectionMarch 25  - United Laboratories International 3933.HK:PROGRESS IN CLINICAL TRIAL OF GROUP'S PRODUCT UBT251 INJECTIONPHASE II CLINICAL TRIAL OF UBT251 INJECTION IN PATIENTS WITH TYPE 2 DIABETES ACHIEVED EXPECTED RESULTSFurther company coverage: 3933.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40C14V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622044266","title":"Triple Agonist Ubt251 Showed a Mean Hba1c Reduction of up to 2.16% After 24 Weeks in Phase 2 Trial in Chinese Patients With Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2622044266","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622044266?lang=en_us&edition=fundamental","pubTime":"2026-03-25 14:00","pubTimestamp":1774418427,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUC1DTSQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132366507","title":"UNITED LAB reports superior Phase II results for triple agonist UBT251; Phase III trial imminent","url":"https://stock-news.laohu8.com/highlight/detail?id=1132366507","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132366507?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:21","pubTimestamp":1774412514,"startTime":"0","endTime":"0","summary":"UNITED LAB (The United Laboratories International Holdings Limited) announced the completion of a 24-week Phase II clinical trial for its Class 1 innovative drug UBT251 Injection in Chinese adults...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622365049","title":"United Laboratories' 2025 Profit Falls 23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622365049","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622365049?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:09","pubTimestamp":1774411742,"startTime":"0","endTime":"0","summary":"The United Laboratories International  booked 2.09 billion yuan in attributable profit for 2025, down 23% from 3.29 billion yuan in 2024, according to a Hong Kong bourse filing Tuesday.Shares of the bulk medicine company fell over 2% in morning trade Wednesday.Earnings per share were 1.1065 yuan, compared with 1.4639 yuan in the prior year.Revenue fell 4% year on year to 13.2 billion yuan, figures showed.The company also proposed a final dividend of 0.26 yuan for the year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","03933","UBCP","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622504600","title":"TUL climbs on UBT251 Phase II completion in China; trial shows HbA1c reduction up to 2.16% and weight loss up to 9.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622504600","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622504600?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:02","pubTimestamp":1774411320,"startTime":"0","endTime":"0","summary":"TUL said its UBT251 injection completed a Phase II study in China for type 2 diabetes, supporting plans to start a Phase III program.The company reported a maximum HbA1c reduction of 2.16% after 24 weeks in the UBT251 arms.It also reported a maximum average weight reduction of 9.8% over 24 weeks, compared with 4.8% for semaglutide 1 mg.TUL said UBT251 has been cleared to run clinical trials in China and/or the US across multiple metabolic indications, which could broaden its commercial scope.The company said it signed an exclusive licensing agreement with Novo Nordisk covering UBT251.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL53B4cw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622604607","title":"United Laboratories International - Phase Ii Clinical Trial of Ubt251 Injection in Patients With Type 2 Diabetes Achieved Expected Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622604607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622604607?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:01","pubTimestamp":1774411311,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40C14V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","03933"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621962310","title":"BRIEF-United Laboratories International Declares Final Dividend Of RMB26 Cents Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2621962310","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621962310?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:22","pubTimestamp":1774365760,"startTime":"0","endTime":"0","summary":"BRIEF-United Laboratories International Declares Final Dividend Of RMB26 Cents Per ShareMarch 24  - United Laboratories International Holdings Ltd 3933.HK:FINAL DIVIDEND OF RMB26 CENTS PER SHAREFY REVENUE RMB13.21 BILLIONPROFIT FOR YEAR ATTRIBUTABLE RMB2.09 BILLIONFurther company coverage: 3933.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C108:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124834307","title":"UNITED LAB (03933) Reports 2025 Financial Results: Profit Attributable to Owners Declines 21.6% to Approximately RMB 20.86 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1124834307","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124834307?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:09","pubTimestamp":1774364984,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) has announced its financial results for 2025. The company recorded revenue of approximately RMB 132.11 billion, a decrease of 4% compared to the previous year. Profit attributable...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148129562","title":"United Laboratories posts weaker FY2025 earnings; revenue slips 4% to RMB 13.21 bn, profit falls 22%, boosts R&D and inks US$1.8 bn Novo Nordisk licensing deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1148129562","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148129562?lang=en_us&edition=fundamental","pubTime":"2026-03-24 23:04","pubTimestamp":1774364640,"startTime":"0","endTime":"0","summary":"United Laboratories (United Laboratories International Holdings Ltd.) reported FY2025 revenue of RMB 13.21 billion, down 4.0% year on year, as lower prices in intermediate and bulk medicine offset...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03933"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tul.com.cn","stockEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":-0.0412},{"period":"3month","weight":-0.1226},{"period":"6month","weight":-0.2215},{"period":"1year","weight":-0.1673},{"period":"ytd","weight":-0.1173}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0203},{"period":"3month","weight":-0.0168},{"period":"6month","weight":0.0454},{"period":"1year","weight":0.2535},{"period":"ytd","weight":0.0298}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.","yearOnYearQuotes":[{"month":1,"riseRate":0.368421,"avgChangeRate":-0.033088},{"month":2,"riseRate":0.736842,"avgChangeRate":0.076003},{"month":3,"riseRate":0.631579,"avgChangeRate":0.024575},{"month":4,"riseRate":0.631579,"avgChangeRate":0.080246},{"month":5,"riseRate":0.666667,"avgChangeRate":0.040685},{"month":6,"riseRate":0.277778,"avgChangeRate":-0.012388},{"month":7,"riseRate":0.526316,"avgChangeRate":0.011895},{"month":8,"riseRate":0.473684,"avgChangeRate":0.025474},{"month":9,"riseRate":0.421053,"avgChangeRate":-0.006971},{"month":10,"riseRate":0.631579,"avgChangeRate":-0.000903},{"month":11,"riseRate":0.473684,"avgChangeRate":-0.023163},{"month":12,"riseRate":0.421053,"avgChangeRate":0.011153}],"exchange":"SEHK","name":"UNITED LAB","nameEN":"UNITED LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"UNITED LAB,03933,UNITED LAB股票,UNITED LAB股票老虎,UNITED LAB股票老虎国际,UNITED LAB行情,UNITED LAB股票行情,UNITED LAB股价,UNITED LAB股市,UNITED LAB股票价格,UNITED LAB股票交易,UNITED LAB股票购买,UNITED LAB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"UNITED LAB(03933),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest UNITED LAB(03933) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}